Mutual Of America Capital Management LLC Halozyme Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

$9.32 Billion
Q3 2024

A detailed history of Mutual Of America Capital Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 178,688 shares of HALO stock, worth $8.68 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

178,688

Previous 183,941 2.86%

Holding current value

$8.68 Million

Previous $9.63 Million 6.14%

% of portfolio

0.11%

Previous 0.11%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$51.3 - $64.42 $269,478 - $338,398	-5,253 Reduced 2.86%	178,688 $10.2 Million
Q2 2024 Aug 09, 2024	BUY	$37.81 - $52.4 $1.65 Million - $2.29 Million	43,614 Added 31.08%	183,941 $9.63 Million
Q1 2024 May 02, 2024	SELL	$33.68 - $41.95 $269,507 - $335,683	-8,002 Reduced 5.39%	140,327 $5.71 Million
Q4 2023 Jan 26, 2024	SELL	$33.32 - $42.1 $236,338 - $298,615	-7,093 Reduced 4.56%	148,329 $5.48 Million
Q3 2023 Nov 09, 2023	SELL	$36.46 - $44.03 $538,732 - $650,587	-14,776 Reduced 8.68%	155,422 $5.94 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $544,616 - $696,777	-17,986 Reduced 9.56%	170,198 $6.14 Million
Q1 2023 May 04, 2023	SELL	$32.86 - $55.7 $195,385 - $331,192	-5,946 Reduced 3.06%	188,184 $7.19 Million
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $61,331 - $91,002	1,531 Added 0.79%	194,130 $11 Million
Q3 2022 Nov 08, 2022	SELL	$38.53 - $51.78 $467,985 - $628,919	-12,146 Reduced 5.93%	192,599 $7.62 Million
Q2 2022 Aug 10, 2022	BUY	$37.35 - $48.3 $2.85 Million - $3.69 Million	76,361 Added 59.48%	204,745 $9.01 Million
Q1 2022 May 02, 2022	BUY	$31.97 - $41.06 $78,358 - $100,638	2,451 Added 1.95%	128,384 $5.12 Million
Q4 2021 Feb 03, 2022	BUY	$31.82 - $40.75 $20,142 - $25,794	633 Added 0.51%	125,933 $5.06 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $251,516 - $303,493	6,538 Added 5.51%	125,300 $5.1 Million
Q2 2021 Aug 06, 2021	BUY	$38.84 - $51.31 $156,952 - $207,343	4,041 Added 3.52%	118,762 $5.39 Million
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $166,179 - $216,398	-4,206 Reduced 3.54%	114,721 $4.78 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $3.07 Million - $5.19 Million	118,927 New	118,927 $5.08 Million

Others Institutions Holding HALO

# of Institutions

544

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.77B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.

Account

Mutual Of America Capital Management LLC Halozyme Therapeutics, Inc. Transaction History